Tag: oncs

StockGuru Corporate Profile: $ONCS – OncoSec Medical Incorporated

StockGuru Spotlight on OncoSec Medical Incorporated(Symbol: ONCS) Help us update information on this company. Email any updates to: updates@stockguru.com About OncoSec Medical Incorporated: Oncosec Medical Incorporated develops novel ElectroOncology therapies that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics. Targeted delivery of these agents is designed to achieve selective destruction of cancerous tumors, resulting in improved functional, cosmetic and quality of life outcomes.   Where it is located: 9810 Summer Ridge RoadSuite 110 San Diego, CA92121 United States   Key Executive Contact: Amy Chan IR   Ninety Day Volume: 1640410 (as of date of publication)

Latest Spotlights

StockGuru Shines its Spotlight on OncoSec Medical Incorporated (OTCBB: ONCS) As It Announces Its Device Master File for OncoSec Medical System Completed and Submitted to FDA — October 21, 2011

(Dallas, TX. – October 21, 2011) StockGuru Shines its Spotlight on OncoSec Medical Incorporated (OTCBB: ONCS).  The Company is developing its advanced-stage OMS ElectroOncology therapies for the treatment of solid tumor cancers, announced today the submission of its Device Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its patented OncoSec Medical System (OMS) which consists of a generator and hand-held applicator.  The Company closed on October 20, 2011, at $0.37, trading in a fifty-two week range of $1.99 – 0.004688. The Company has been developing the OncoSec Medical System as its lead medical device for delivering DNA

Latest Spotlights

StockGuru Shines its Spotlight on OncoSec Medical Incorporated (OTCBB: ONCS) which Is Developing Therapies to Treat Solid Tumor Cancers – July 11, 2011

Dallas, Texas (July 11 , 2011) – StockGuru shines its Spotlight on OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers.  The Company announced today that it will present at the Annual DNA Vaccines Conference, hosted by the International Society of DNA Vaccines, July 12-14 at the Loews Coronado Bay hotel in San Diego, California. This year’s conference is themed, “Building on Clinical Progress and Exploring New Targets.”  OncoSec Medical Incorporated closed on Friday July 8, 2011, at $0.90 trading on volume of roughly 37,000 shares. Richard Heller, Ph.D., director of

Latest Spotlights

StockGuru Shines its Spotlight on OncoSec Medical Inc. (OTCBB: ONCS) A Company Developing Advanced-stage ElectroOncology Therapies to Treat Solid Tumor Cancers on July 5, 2011

Dallas, Texas (July 5 , 2011) – StockGuru shines its Spotlight on OncoSec Medical Inc. (OTCBB: ONCS) which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers.  The Company  announced today the appointment of Brian McCluskey as Executive Director, Engineering, who will lead the development of the company’s proprietary electroporation delivery technology, the OncoSec Medical System (OMS).  The Company closed at $1.07 on July 1, 2011, trading on volume of roughly 65,000 shares. Punit Dhillon, OncoSec’s President and CEO, said, “We are pleased that Brian will join  our management team. He brings a proven track record of medical

StockGuru Spotlight May 27, 2011: RSCF Up As Much As 56%; SMDI Up As Much As 55% and more

StockGuru Spotlight May 26, 2011 ONCS, TBBC, GLOI, GETH, OEDV, PGSI Dear Members: These Spotlights have made tremendous moves.  As you can see, StockGuru brings you the very stocks you want on your radar, in your portfolio and to trade. These Companies continue to hit new highs.  Check out the StockGuru Spotlight potential. While we know you can never catch the absolute high or the absolute low, these Companies represent the StockGuru Spotlight potential. StockGuru Spotlight Spotlight Price Symbol High Up As Much As Market Cap May 13, 2011 $ 0.09 RSCF $ 0.14 56% 4.74M March 22, 2011 $

Latest Spotlights

OncoSec Medical Inc. is in the StockGuru Spotlight for May 27, 2011

DALLAS, TEXAS : StockGuru announces that OncoSec Medical Inc. (OTCBB: ONCS) is in the StockGuru Spotlight.    Oncosec Medical develops novel ElectroOncology therapies that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics. Targeted local delivery of these agents is designed to achieve selective destruction of cancerous tumors while sparing healthy normal tissue, resulting in improved functional, cosmetic and quality of life outcomes. These therapies have achieved validating safety and efficacy data in early and late stage clinical studies of over 400 cancer patients. OncoSec’s clinical programs include three Phase II clinical trials. On Thursday, the company put